FILGRASTIM

Filgrastim is a GCSF analog stimulating neutrophil production, used in neutropenia. Side effects include bone pain, splenomegaly, fever, and rare acute respiratory distress. Only GMP materials will be supplied, logistics all according to GDP.

Category:

Product Description


Mechanism of Action

FILGRASTIM demonstrates a highdimensional biochemical activity framework integrating catalyticdomain modulation, multiaxis signalling interference, mitochondrialnetwork recalibration, redoxequilibrium restructuring, ionflux redistribution, membranepotential modulation, cytoskeletalarchitecture remodelling and transcriptionfactor circuit reprogramming. The compounds molecular topology supports interaction with catalytic residues, allosteric microdomains, transmembrane helices, nucleotidebinding pockets, redoxbuffer matrices and polymeric scaffolding complexesenabling influence across metabolic, genomic, structural and electrophysiological systems.

FILGRASTIM may alter phosphorylationflow geometry across ERK, MAPK, JNK, p38 and PI3KAKT axes; reconfigure Gprotein signalstate logic; redistribute Ca²⁺ microdomains; adjust IP/DAG signalling topology; and recalibrate cAMPPKA amplitude. Mitochondrial effects include ETCcomplex rebalancing, ATP/ADP flux modulation, ROSthreshold displacement, membranepotential polarity shifting, and ERmitochondria stresssignal crosstalk integration.

HighPrecision

  • Kinomescale interference mapping & catalyticcascade modelling
  • Highresolution molecular docking & conformationaltransition prediction
  • UPR/ERstress, mitophagy & autophagicflux regulatory modelling
  • Multiomics network reconstruction: RNAseq, metabolomics, proteomics, phosphoproteomics
  • Cytoskeletal tensionmapping & polymerturnover analytics
  • Advanced cellfate pathway modelling (apoptosis, necroptosis, ferroptosis, parthanatos)
  • AIdriven SAR/QSAR predictive compoundperformance optimisation

Toxicodynamics & Hazard Spectrum

  • Rapid ROS escalation & antioxidantbuffer collapse
  • Mitochondrial fragmentation or ETCaxis suppression
  • Severe Na⁺/K⁺/Ca²⁺ ionic-flux destabilisation
  • Cytoskeletal depolymerisation & membrane-integrity loss
  • Inflammatory hyperactivation (NF-κB, STAT, IRF signalling clusters)
  • Activation of multiaxis programmed-cell-death pathways
  • Epigenetic drift including methylation/acetylation instability

For expert not intended for biological or therapeutic exposure.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C845H1313N233O243S9

Molecular Weight

18912.73 g/mol

CAS Number

123629-15-8

Storage Condition

Store at 28°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

IUPAC/Chemical Name

Granulocyte-colony stimulating factor

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download